New: Clinical trial search, funded by the National Cancer Institute
New: NCI-funded clinical trial search
Community
Tools
Company
Support
Sign in
Join for Free
Join for Free
Community
How do you counsel patients with genetically confirmed Fabry disease regarding switching from agalsidase beta (Fabrazyme) to Migalastat (Galafold)?
Assuming they have an amenable gene
Good Question
Save
Request Answers
Share
Add Answer
